Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Santoro

Showing results (61-70 of 201) with videos related to

Pageof 21
Sort By:
Cancer Research|December 20, 2007
Cytosolic phospholipase A2 alpha regulates cell growth in RET/PTC-transformed thyroid cellsStefania Mariggiò, Beatrice Maria Filippi, Cristiano Iurisci, et al.
Scientific Reports|November 25, 2025
Discovery of a Proteolysis Targeting Chimera for TRKA and RET-derived oncoproteinsMarialuisa Moccia, Lingzhi Zhang, Zhengyu Wang, et al.
Cancer Research|June 17, 2006
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteinsAngela Iervolino, Rodolfo Iuliano, Francesco Trapasso, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinomaValentina De Falco, Riccardo Giannini, Anna Tamburrino, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2)Francesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.
Cancer Research|February 28, 2002
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenesFrancesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.
The Journal of Biological Chemistry|February 18, 2006
Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogeneCarlo Iavarone, Mario Acunzo, Francesca Carlomagno, et al.
Endocrine-Related Cancer|November 26, 2008
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474Francesca Carlomagno, Teresa Guida, Suresh Anaganti, et al.
European Journal of Pain (London, England)|November 30, 2019
ZNRD1-AS and RP11-819C21.1 long non-coding RNA changes following painful laser stimulation correlate with laser-evoked potential amplitude and habituation in healthy subjects: A pilot studyMassimo Santoro, Catello Vollono, Costanza Pazzaglia, et al.
Brain Sciences|June 2, 2021
Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation TreatmentMariacristina Siotto, Marco Germanotta, Massimo Santoro, et al.
Pageof 21

Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
Cancer Research|December 20, 2007
Cytosolic phospholipase A2 alpha regulates cell growth in RET/PTC-transformed thyroid cellsStefania Mariggiò, Beatrice Maria Filippi, Cristiano Iurisci, et al.
Scientific Reports|November 25, 2025
Discovery of a Proteolysis Targeting Chimera for TRKA and RET-derived oncoproteinsMarialuisa Moccia, Lingzhi Zhang, Zhengyu Wang, et al.
Cancer Research|June 17, 2006
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteinsAngela Iervolino, Rodolfo Iuliano, Francesco Trapasso, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinomaValentina De Falco, Riccardo Giannini, Anna Tamburrino, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2)Francesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.
Cancer Research|February 28, 2002
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenesFrancesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.
The Journal of Biological Chemistry|February 18, 2006
Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogeneCarlo Iavarone, Mario Acunzo, Francesca Carlomagno, et al.
Endocrine-Related Cancer|November 26, 2008
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474Francesca Carlomagno, Teresa Guida, Suresh Anaganti, et al.
European Journal of Pain (London, England)|November 30, 2019
ZNRD1-AS and RP11-819C21.1 long non-coding RNA changes following painful laser stimulation correlate with laser-evoked potential amplitude and habituation in healthy subjects: A pilot studyMassimo Santoro, Catello Vollono, Costanza Pazzaglia, et al.
Brain Sciences|June 2, 2021
Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation TreatmentMariacristina Siotto, Marco Germanotta, Massimo Santoro, et al.
Pageof 21